No Data
No Data
Oppenheimer Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $65
Tarsus Pharmaceuticals Insider Lowered Holding By 16% During Last Year
Guggenheim Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating
Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's Is How to Trade
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Have Been Lifting Their Price Targets
A Quick Look at Today's Ratings for Tarsus Pharmaceuticals(TARS.US), With a Forecast Between $65 to $84
Unlock the Full List